Philadelphia nonprofit has concerns about Trump administration's plan to dismantle CDC's HIV prevention division
defund critical HIV prevention initiatives
.
The Trump administration is reportedly considering dismantling the Centers for Disease Control and Prevention's division dedicated to HIV prevention, a move that could shift its responsibilities to another department within the U.S. Department of Health and Human Services.
This potential restructuring has drawn strong condemnation from health organizations across the country, particularly those in the LGBTQ+ and HIV communities, who fear it could jeopardize years of progress in the fight against HIV/AIDS.
David Fair is a long-time HIV/AIDS advocate in Philadelphia and played a key role in the city's early response to the epidemic.
Fair, who co-founded organizations such as the Philadelphia Lesbian and Gay Task Force and Lavender Health (now known as the Mazzoni Center), warns that dismantling the CDC's HIV programs would undo decades of work and could result in a resurgence of new infections and unnecessary deaths.
"If the president gets what he's looking to do, we're going to have more people dying from AIDS," said Fair. "I believe at a rate that we haven't seen for years and years and years because there simply won't be the infrastructure."
Fair's involvement with the HIV/AIDS crisis dates back to the 1980s, when the disease was still largely misunderstood and stigmatised, and its effects were devastating the gay community.
"We called it the gay cancer," Fair recalls, remembering how those diagnosed with HIV often faced death within a few months. At the time, there were few treatment options, and the response from public health officials was slow and reluctant.
Despite the overwhelming challenge, Fair and others in Philadelphia worked to create a robust system of care for people living with HIV, including specialized programs for those dealing with mental illness, drug addiction, and other vulnerabilities.
"We didn't just take a public health approach; we took a comprehensive approach," Fair said. This approach, which focused on addressing the complex needs of people with HIV, has continued to shape the city's HIV care system to this day.
Fair's personal connection to the epidemic has only grown stronger over the years. He recently lost his husband, Rudy, to kidney disease complicated by HIV, a painful reminder of the ongoing struggles of people living with the virus.
One organization that could be significantly impacted by changes to federal HIV funding is the Mazzoni Center, serving the LGBTQ+ community and others for 45 years. With an estimated 18,000 people living with HIV in Philadelphia, the Mazzoni Center plays a pivotal role in providing HIV care, treatment, prevention and education.
Dr. Stacey Trooskin, the Chief Medical Officer at Mazzoni, expressed deep concern about the potential loss of federal funding.
"HIV prevention dollars make all of the programmatic work possible," Trooskin said. "Without those dollars, we'll be at a true disadvantage."
She added that many of their patients are already worried about losing access to crucial HIV medications, such as PrEP (pre-exposure prophylaxis), as well as treatment options for those already living with HIV.
"There are many patients coming in right now who are scared," Trooskin explained. "They're scared they won't have access to their HIV medications, and they won't have access to the support they need to stay healthy."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
GoHealth Second Quarter 2025 Earnings: Misses Expectations
Explore GoHealth's Fair Values from the Community and select yours GoHealth (NASDAQ:GOCO) Second Quarter 2025 Results Key Financial Results Revenue: US$94.0m (down 11% from 2Q 2024). Net loss: US$55.2m (loss widened by 105% from 2Q 2024). US$5.10 loss per share (further deteriorated from US$2.70 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period GoHealth Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 100%. Looking ahead, revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Performance of the American Insurance industry. The company's share price is broadly unchanged from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for GoHealth you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
NBC News
5 hours ago
- NBC News
Las Vegas' growing mosquito problem is 'a ticking time bomb'
LAS VEGAS — If at one time it was thought mosquitoes couldn't survive in desert climates, this city is a case study in how wrong that is. Mosquitoes typically prefer more tropical, humid conditions, but these biting machines have exploded in number throughout the Las Vegas Valley in recent years because of a host of changes. A mix of urban development, climate change, insecticide resistance and genetic adaptations are creating a more hospitable environment for the insects in southern Nevada. Las Vegas is hardly alone in its battle against the pesky insects. Warmer temperatures and shifting weather patterns are expanding the geographic range in which mosquitoes live and breed. In many ways, what's happening here is playing out across the desert Southwest, and beyond. The mosquitoes have brought with them not only the nuisance of bug bites, but also the major threat of mosquito-borne diseases such as dengue fever and West Nile virus to Las Vegas and the rest of Clark County. It's also caught people off guard. 'People aren't wrong that mosquitoes shouldn't really thrive in desert conditions, but it's clear that the particular set of species that we do have in Clark County has adapted to the local ecology,' said Louisa Messenger, an assistant professor in the department of environmental and global health at the University of Nevada, Las Vegas. 'A ticking time bomb' The species that have taken hold in Clark County include Culex mosquitoes, which can carry West Nile virus, and Aedes aegypti mosquitoes, the primary spreaders of dengue. What's more, Messenger and her colleagues at UNLV have found that mosquitoes in Las Vegas are becoming resistant to insecticides, a major public health risk in a city built on tourism. 'It is a little bit of a ticking time bomb,' Messenger said. She has for some time been concerned about how vulnerable Las Vegas is to mosquito-borne diseases. In particular, dengue has been surging in North America and South America, with more than 13 million cases recorded across the continents in 2024, according to the Centers for Disease Control and Prevention. 'In Vegas, we have more than 48 million visitors coming through our doors every year from all over the planet,' Messenger said. 'It just takes a couple of mosquito bites to start local transmission.' Last year, there were 26 reported cases of West Nile virus in humans in Las Vegas, according to the Southern Nevada Health District, trailing the city's largest outbreak of 43 cases in 2019. Yet, in 2024, scientists still found a record number of mosquitoes that tested positive for the virus in and around the city, which suggests the risk of exposure was very concerning. This year, the public health department hasn't identified any human cases so far, even as mosquitoes have tested positive for the virus in certain ZIP codes. Messenger said it's not well understood what specific factors fuel outbreaks in some years and not in others. 'We see these overlapping factors but they are quite difficult to tease it apart,' she said. 'All we can say for certain is that we have these bumper years and these zero years, and they are hard to predict.' The Southern Nevada Health District has been conducting mosquito surveillance in the region since 2004. Its meticulous records show which mosquito species are present across the Las Vegas Valley year after year and where these flying insects have tested positive for diseases. One of the most astonishing trends in the data was the explosive growth of Aedes aegypti mosquitoes, which were first identified in Las Vegas in 2017, said Vivek Raman, environmental health supervisor for the Southern Nevada Health District. The 'relentless biters' are spreading 'In 2017, this mosquito was found in just a few ZIP codes,' said Raman, who oversees the health district's mosquito surveillance program. 'A few years later, it was six ZIP codes. Then 12 ZIP codes, then maybe 20, and now it's in 48 different ZIP codes across the valley.' In addition to being able to spread dengue, these insects are a major nuisance. 'Aedes aegypti are very aggressive daytime-biting mosquitoes,' Raman said. 'They are just relentless biters.' Unlike Culex mosquitoes, which prefer breeding near larger sources of water such as untended swimming pools, culverts or detention basins, Aedes aegypti tend to breed in much shallower standing water. 'One of the reasons they are spreading so quickly is the mosquito can lay its eggs in small containers, like if rain fills a child's toy or tires or a wheelbarrow,' Raman said. 'All it takes is a couple inches of water.' Urban development in Las Vegas has also inadvertently spurred the spread of mosquitoes in the city. Golf courses, human-made lakes and other forms of artificial irrigation have all made this outpost in the Nevada desert a welcome home for mosquitoes, according to Messenger. Climate change is likely also a factor, and it's an active area of research for Messenger and other scientists. Warmer temperatures are expanding the range of geographies for mosquitoes around the world. A warmer atmosphere can also hold more moisture, which increases humidity and rain, both mosquito-friendly conditions. In Las Vegas, how the interplay between local environmental factors and changing climate trends is affecting mosquito populations is less well understood, but the implications are paramount. 'Las Vegas is kind of a case study for what climate change is going to look like in other parts of the world,' Messenger said. 'We're seeing record-breaking temperatures, we're becoming much more arid, precipitation is becoming much more aberrant and unpredictable. That's what large parts of the world are going to look like over the next 15 to 25 years.' What that means for mosquitoes in the city remains to be seen, but the problem so far shows no sign of slowing. The Southern Nevada Health District conducts public outreach on how to identify and protect against mosquito breeding sites in and around homes, and how to prevent mosquito bites. But, controlling the number of mosquitoes in the city — and thus controlling the public health risk — will require a coordinated effort from the local government, Messenger said. Currently, there isn't one in Las Vegas. 'You've got private pest companies that people can call for severe infestations, you have some work going on around wetlands, but what we don't have, which many other jurisdictions have, is a centralized, coordinated abatement,' Messenger said. That lack of coordination has resulted in mosquito populations building up resistance to insecticides, she added. A centralized effort could assess which chemicals are safe to use — particularly around humans — and monitor the performance of insecticides and pesticides to prevent mosquitoes from building up immunity. In the years ahead, Messenger said, prevention and control will be key to protecting the residents of Las Vegas and its many visitors from around the world. 'The bottom line is that this is entirely preventable,' she said. 'Nobody in southern Nevada, in Clark County, should be getting bit by mosquitoes and contracting any kind of virus.'
Yahoo
7 hours ago
- Yahoo
Elevance Health (NYSE:ELV) Is Reinvesting At Lower Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Having said that, from a first glance at Elevance Health (NYSE:ELV) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. What Is Return On Capital Employed (ROCE)? For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Elevance Health, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.11 = US$8.7b ÷ (US$122b - US$44b) (Based on the trailing twelve months to June 2025). So, Elevance Health has an ROCE of 11%. By itself that's a normal return on capital and it's in line with the industry's average returns of 11%. See our latest analysis for Elevance Health In the above chart we have measured Elevance Health's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Elevance Health for free. What Does the ROCE Trend For Elevance Health Tell Us? In terms of Elevance Health's historical ROCE movements, the trend isn't fantastic. Around five years ago the returns on capital were 14%, but since then they've fallen to 11%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. The Bottom Line While returns have fallen for Elevance Health in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. These trends are starting to be recognized by investors since the stock has delivered a 16% gain to shareholders who've held over the last five years. Therefore we'd recommend looking further into this stock to confirm if it has the makings of a good investment. Elevance Health could be trading at an attractive price in other respects, so you might find our on our platform quite valuable. For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
